Recently, two novel immune checkpoint molecules, T cell immunoreceptor with Ig and immunoreceptor tyrosine‐based inhibition motif (ITIM)domains (TIGIT), and natural‐killer group 2 member A (NKG2A), have emerged as potential prognostic markers in certain cancers [11]. Here, TIGIT is linked to cancer.